Advertisement

http://insurancethoughtleadership.com/wp-content/uploads/2014/04/bg-h1.png

[sendtokindle]

MaryRose Reaston

MaryRose Reaston

MaryRose Reaston is the co founder, CEO and CSO of Emerge Diagnostics, a company created to commercialize the electrodiagnostic functional assessment (EFA). Emerge Diagnostics focuses on better outcomes for Musculoskeletal Disorders via early resolution and enhanced treatment options for soft-tissue injuries.

Recent Articles by MaryRose Reaston

What An Employer Can Do To Reduce Soft Tissue Injuries In The Transportation Industry

The trucking industry accounted for nearly 20 percent of all days-away-from-work cases in 2011. Correspondingly, trucking was among the seven occupations which had an incidence rate greater than 300 cases per 10,000 full-time workers and who had greater than 20,000 days-away-from-work cases. OSHA defines a Musculoskeletal Disorder (MSD) as an injury of the muscles, nerves, […]

Connect With MaryRose Reaston

Connect with Dave Walker on LinkedIn Connect with Dave Walker on Facebook

  • Enterprise Risk Management
  • Healthcare
  • Insurance Law
  • Workers Compensation